# Tilapia Skin in Burn Injuries: A Narrative Review of Pathophysiology, Current Management, and Therapeutic Applications

**Authors:** Mateusz Szot, Mikolaj Zakrys, Katarzyna Zakrys, Szymon Stupnicki, Aleksandra Oparcik, Jakub Tarczykowski, Natalia Kwasniewska, Mieszko Czaplinski

PMC · DOI: 10.7759/cureus.102556 · Cureus · 2026-01-29

## TL;DR

Tilapia skin shows promise as a cost-effective treatment for burn injuries, offering faster healing and reduced pain compared to traditional methods.

## Contribution

This paper reviews the potential of tilapia skin in burn treatment, highlighting its unique properties and advantages over conventional therapies.

## Key findings

- Tilapia skin promotes faster re-epithelialization and reduces pain in burn wound healing.
- It has antimicrobial and anti-inflammatory properties, lowering infection risk and adverse reactions.
- Tilapia skin is cost-effective and accessible, making it suitable for low-resource settings.

## Abstract

Burn wounds are common worldwide and often require prolonged treatment and recovery time. Such injuries are associated with local and systemic changes, both of which require effective action to prevent deterioration and improve long-term outcomes. The most common division of burns is based on injury depth. Treatment differs depending on the extent of the injury. The social and financial burden of burns is heavy, with some survivors being excluded from society. Due to high treatment costs and restricted availability of some management options, patients in low-resource settings may not receive the most advanced care. Therefore, new cost-effective and easily accessible management options are desired to improve clinical outcomes and provide an alternative to traditional methods. Nile tilapia skin showed promising results in burn wound treatment in preclinical and clinical studies. Unique antimicrobial, anti-inflammatory, and molecular properties of tilapia skin, combined with a structure similar to human cutis, are associated with enhanced wound healing and faster re-epithelialization. In animals, tilapia skin showed promising results in wound healing of various depths. In humans, superficial partial-thickness burns were mostly examined. In comparison to conservative management, patients treated with tilapia skin experienced lower pain intensity, required fewer dressing changes, and decreased analgesic intake. Re-epithelialization was faster. Advantages over traditional methods include a lack of local adverse reactions, low infection risk, reduced pain, cost-effectiveness, ease in tilapia skin acquisition, and application. Clinical studies restricted to a small number of participants and a lack of research on humans in various burn depths limit the broader employment of tilapia skin. Data on long-term outcomes are scarce; therefore, more studies need to be performed in that area to create clear guidelines and standardized treatment protocols. However, the beneficial effects of tilapia skin on wound healing are very promising and have high potential for development. In the future, it might become a cornerstone of burn injury treatment and improve clinical outcomes, particularly in low-resource settings.

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** pulmonary edema (MESH:D011654), multiorgan failure (MESH:D051437), SS (MESH:C536644), ischemic (MESH:D002545), thermal injuries (MESH:D020886), pain (MESH:D010146), Tilapia Skin (MESH:D012871), skin injuries (MESH:D000069836), Burn wounds (MESH:D014947), inflammation (MESH:D007249), muscle wasting (MESH:D009133), Burn Injuries (MESH:D002056), ischemia (MESH:D007511), scars (MESH:D002921), prion disease (MESH:D017096), infected wounds (MESH:D014946), compartment syndromes (MESH:D003161), nociceptive (MESH:D059226), infection (MESH:D007239), reduced cardiac output (MESH:D002303), death (MESH:D003643), sepsis (MESH:D018805), septic shock (MESH:D012772), necrosis (MESH:D009336), muscle loss (MESH:D009135), cardiac depression (MESH:D006331), heart failure (MESH:D006333)
- **Chemicals:** polymers (MESH:D011108), glycans (MESH:D011134), oxygen (MESH:D010100), Methicillin (MESH:D008712), hyaluronic acid (MESH:D006820), silver (MESH:D012834), testosterone (MESH:D013739), fentanyl (MESH:D005283), EPA (MESH:D015118), SS (MESH:D012837), Propranolol (MESH:D011433), dipyrone (MESH:D004177), growth hormone (MESH:D013006), DPTB (-), oxandrolone (MESH:D010074), DHA (MESH:D004281), lipid (MESH:D008055), carboxymethylcellulose (MESH:D002266)
- **Species:** Ctenopharyngodon idella (grass carp, species) [taxon 7959], Canis lupus familiaris (dog, subspecies) [taxon 9615], Equus asinus (African ass, species) [taxon 9793], Mus musculus (house mouse, species) [taxon 10090], Gadus morhua (Atlantic cod, species) [taxon 8049], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Staphylococcus aureus (species) [taxon 1280], Tilapia (genus) [taxon 8126], Oreochromis niloticus (Nile tilapia, species) [taxon 8128], Actinopterygii (fishes, superclass) [taxon 7898], Bos taurus (bovine, species) [taxon 9913], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]
- **Cell lines:** Tilapia — Oreochromis mossambicus x Oreochromis niloticus (Hybrid tilapia), Spontaneously immortalized cell line (CVCL_R879)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949593/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949593/full.md

---
Source: https://tomesphere.com/paper/PMC12949593